Susquehanna International Group’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.5K | Buy |
40,619
+6,936
| +21% | +$10.3K | ﹤0.01% | 6000 |
|
|
2025
Q1 | $47.8K | Buy |
33,683
+21,556
| +178% | +$30.6K | ﹤0.01% | 6024 |
|
|
2024
Q4 | $24.5K | Sell |
12,127
-25,673
| -68% | -$51.9K | ﹤0.01% | 5980 |
|
|
2024
Q3 | $66.5K | Buy |
37,800
+12,748
| +51% | +$22.4K | ﹤0.01% | 5229 |
|
|
2024
Q2 | $58.4K | Sell |
25,052
-27,078
| -52% | -$63.1K | ﹤0.01% | 5246 |
|
|
2024
Q1 | $74.5K | Buy |
52,130
+17,586
| +51% | +$25.1K | ﹤0.01% | 5082 |
|
|
2023
Q4 | $58.7K | Sell |
34,544
-37,635
| -52% | -$64K | ﹤0.01% | 5513 |
|
|
2023
Q3 | $135K | Buy |
72,179
+57,282
| +385% | +$107K | ﹤0.01% | 4780 |
|
|
2023
Q2 | $35.6K | Sell |
14,897
-5,831
| -28% | -$13.9K | ﹤0.01% | 5277 |
|
|
2023
Q1 | $41K | Buy |
+20,728
| New | +$41K | ﹤0.01% | 5472 |
|
|
2022
Q2 | – | Sell |
-1,344
| Closed | -$9K | – | 5917 |
|
|
2022
Q1 | $9K | Buy |
+1,344
| New | +$9K | ﹤0.01% | 5567 |
|
|
2018
Q4 | – | Sell |
-867
| Closed | -$26K | – | 3823 |
|
|
2018
Q3 | $26K | Buy |
+867
| New | +$26K | ﹤0.01% | 3156 |
|